US › Healthcare

Clearmind Medicine Inc. Common Shares (CMND)

US · Healthcare · Biotechnology

$6.26-2.49%

Last close · 2026-10-16

Latest quarter · ended 2026-07-31

Revenue

Net profit

$-907,291

EPS

$-0.57

Key statistics

Market cap

$3.3M

Forward P/E

0.0

P/B

0.22

Book value

$48.30

EPS (TTM)

$-461.20

52-week high

$3,840.00

52-week low

$5.25

50-day MA

$10.02

200-day MA

$58.41

Beta

0.46

Shareholding

Insiders

0.03%

Institutions

1.21%

Largest institutional holders

Fund	Stake
HRT FINANCIAL LLC	0.87%
Citadel Advisors Llc	0.29%
AdvisorShares Investments, LLC	0.03%
Morgan Stanley - Brokerage Accounts	0.02%
Royal Bank of Canada	0.01%
Caitong International Asset Management Co., Limited.	0.00%
JPMorgan Chase & Co	0.00%
XTX Topco Ltd	0.00%

Corporate actions

Action	Detail	Date
Split	1 : 8 effective Oct 5, 2026	2026-10-05

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Clearmind Medicine Inc. Common Shares — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.